Ignite Creation Date:
2025-12-24 @ 2:34 PM
Ignite Modification Date:
2026-06-08 @ 3:28 PM
Study NCT ID:
NCT03632759
Status:
COMPLETED
Last Update Posted:
2022-01-24
First Post:
2018-08-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Targeting Beta Cell Dysfunction With Liraglutide or Golimumab in Longstanding T1D
Sponsor:
Carla Greenbaum, MD
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
IRB18-044
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |